HOME >> MEDICINE >> NEWS
Leading immunosuppressant CellCept significantly extends the lifespan of transplanted kidneys

The analysis showed that after three years treatment with CellCept + tacrolimus, kidney survival was 85.9% versus 80.3% with patients taking sirolimus + tacrolimus immunosuppressants. The outcome was even better for higher risk patients with a kidney survival rate of 74.5% vs 57.5%[i]. The new data were presented at the European Society for Organ Transplantation (ESOT), Geneva, Switzerland. Previous data have shown that CellCept gives a survival benefit when compared to older immunosuppressant drugs and now these new data demonstrate the survival benefit of CellCept combinations over the newer drug regimens.

Kidneys are the most commonly transplanted organs[ii]; for every kidney available there are four people waiting to receive one[iii]. After transplantation, people need to take a combination of immunosuppressant drugs for the rest of their lives to prevent the body rejecting the new organ. By preserving the transplanted organ with CellCept based combinations, doctors can help patients to keep their organs longer, thereby, reducing the burden on the already limited donor pool. One way to achieve this is by choosing combinations based on the low toxicity profile of CellCept, along with reduced doses of the more toxic immunosuppressant drugs to decrease the risk of losing the new kidney.

"We have learnt that the combination of cyclosporine/sirolimus is toxic to the kidney over time and as a result some doctors have switched to a sirolimus/tacrolimus combination, that was perceived to be less toxic," said Prof Herwig-Ulf Meier Kriesche, University of Florida, Gainesville, Fl, USA. "Now we have the data to show that this combination is just as damaging. These data, along with this latest analysis of patients on CellCept combinations, should help us make an evidence-based choice on how best to reduce the risk of toxicity, which we know is associated with some long-term immunosuppressant regimens," he added.


'"/>

Contact: Helen Swift
helen.swift@ketchum.com
+44-20-7611-3637
Ketchum
19-Oct-2005


Page: 1

Related medicine news :

1. Leading prevention researchers meeting in Washington, D.C., May 30-June 1, 2007
2. Leading advocates express support for microbicide research, despite disappointing trial results
3. Leading European experts in magnetic resonance for animals
4. Leading healthcare authorities to address safety and effectiveness
5. Leading international osteoporosis experts to present at worlds largest osteoporosis congress
6. Leading hepatology textbook edited by SLU researchers
7. Leading groups offer NIH direct links to journals to make research access easy for public
8. Leading pediatricians group recommends infants sleep in cribs, not parents beds
9. Leading genomic technology expert to present Dickson Prize Lecture at Pitt
10. Leading experts discuss how to protect premature infants against RSV, a potentially dangerous virus
11. Leading sleep expert at Wake Forest to speak at NIH Consensus Conference

Post Your Comments:
(Date:3/31/2015)... NC (PRWEB) March 31, 2015 Smartlink ... engagement technology, today announced that Chris Lynch, Managing ... Annual Southeast Venture Conference (SEVC) this week in Charlotte, ... technology firms in the southeast region and provides these ... capitalists and private equity investors. , This year’s ...
(Date:3/31/2015)... 2015 These two automakers will address ... ecosystem. They will highlight a shift that has become ... insurance a business proposition for the insurance carriers alone. ... the opportunities that lie in store for them. ... automakers are now alive to their own involvement in ...
(Date:3/31/2015)... MA and Willimantic, CT (PRWEB) March 31, 2015 ... the word about the settlement of a nationwide ... No. 5:11-CV-17, District of Vermont) and seeking to ... to patients who did not meet an “improvement ... Medicare Advocacy are releasing a video conversation with ...
(Date:3/31/2015)... 2015 April is Parkinson’s disease Awareness Month ... announce 30 Days, 30 Ways to Make a Difference. ... that will offer a new action each day throughout April ... who battle this disease. , Every nine minutes ... alone nearly 5,000 individuals in this country will learn they ...
(Date:3/31/2015)... Azilen Technologies adds yet another ... Development Company’ award at GESIA 2015. The firm earned ... Annual Award GESIA 2015. This marks Azilen’s second triumph ... It previously won the ‘Best Product Innovation’ award at ... product development, enterprise mobility solutions and open source technologies. ...
Breaking Medicine News(10 mins):Health News:Smartlink Mobile Chosen to Present at Southeast Venture Conference 2Health News:TU-Automotive: Fiat and Renault-Nissan at the Centre of a Motor Insurance Evolution 2Health News:Mythbusters: Harmony Healthcare International and Center for Medicare Advocacy Team-Up to Dispel Myths On Medicare Coverage for Maintaining a Patient’s Condition 2Health News:Mythbusters: Harmony Healthcare International and Center for Medicare Advocacy Team-Up to Dispel Myths On Medicare Coverage for Maintaining a Patient’s Condition 3Health News:Mythbusters: Harmony Healthcare International and Center for Medicare Advocacy Team-Up to Dispel Myths On Medicare Coverage for Maintaining a Patient’s Condition 4Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 2Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 3Health News:Azilen Technologies Receives ‘Best Product Development Company’ Award at GESIA 2015 2
(Date:3/31/2015)... 31, 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or ... quality medical marijuana products and a licensed producer ("LP") ... Regulations ( Canada ) ("MMPR"), is pleased ... Corporation of the District of Saanich ... premises which now allows for commercial distribution of medical ...
(Date:3/31/2015)... 31, 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... Hydrochloride 150mg, 225mg and 300mg oral tablets, indicated for ... US market for Propafenone Hydrochloride 150mg, 225mg and 300mg ... Arthur S. Przybyl , President and ... the launch of our fourth product from the portfolio ...
(Date:3/31/2015)... DUBLIN , Mar. 27, 2015 Research ... announced the addition of the "European Laboratory ... Information System), by Type (Clinical Pathology Laboratory Information ... to 2019" report to their offering. ... estimated to grow at a CAGR of 7.6% ...
Breaking Medicine Technology:T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 2European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 3
Cached News: